{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:48:41Z","timestamp":1791139721066,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS117757"],"award-info":[{"award-number":["R01-NS117757"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS127895"],"award-info":[{"award-number":["R01-NS127895"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"The Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["021160"],"award-info":[{"award-number":["021160"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.actbio.2026.03.031","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:41:33Z","timestamp":1773909693000},"page":"51-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Biopreservation of a tissue engineered nigrostriatal pathway for tract reconstruction in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-4343","authenticated-orcid":false,"given":"Dimple","family":"Chouhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wisberty J. Gordi\u00e1n","family":"V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0448-9367","authenticated-orcid":false,"given":"Saarang P.","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera N.A.","family":"Yankson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Shultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7282-2201","authenticated-orcid":false,"given":"John E.","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-5216","authenticated-orcid":false,"given":"D. Kacy","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.03.031_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41531-019-0105-5","article-title":"Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease","volume":"6","author":"Harris","year":"2020","journal-title":"NPJ. Parkinsons. Dis."},{"issue":"11","key":"10.1016\/j.actbio.2026.03.031_bib0002","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/124.11.2131","article-title":"Pathophysiology of bradykinesia in Parkinson's disease","volume":"124","author":"Berardelli","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.actbio.2026.03.031_bib0003","unstructured":"G. DeMaagd, A. Philip, Parkinson's Disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis, P t 40(8) (2015) 504\u201332."},{"issue":"2","key":"10.1016\/j.actbio.2026.03.031_bib0004","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","article-title":"Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum","volume":"29","author":"Matsuda","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson's disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"Lewitt","year":"2015","journal-title":"Mov. Disord."},{"issue":"7378","key":"10.1016\/j.actbio.2026.03.031_bib0006","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.actbio.2026.03.031_bib0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","article-title":"Preclinical efficacy and safety of a Human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01","volume":"28","author":"Piao","year":"2021","journal-title":"Cell Stem Cell."},{"key":"10.1016\/j.actbio.2026.03.031_bib0008","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0079-6123(10)84014-2","article-title":"Neural grafting in Parkinson's disease problems and possibilities","volume":"184","author":"Brundin","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.actbio.2026.03.031_bib0009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.expneurol.2013.09.022","article-title":"Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF","volume":"250","author":"Zhang","year":"2013","journal-title":"Exp. Neurol."},{"issue":"22","key":"10.1016\/j.actbio.2026.03.031_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213985","article-title":"Axonal tract reconstruction using a tissue-engineered nigrostriatal pathway in a rat model of Parkinson’s disease","volume":"23","author":"Struzyna","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2026.03.031_bib0011","article-title":"Dopaminergic axon tracts within a hyaluronic acid hydrogel encasement to restore the nigrostriatal pathway","volume":"14","author":"Gordi\u00e1n-V\u00e9lez","year":"2025","journal-title":"Adv Heal. Mater."},{"issue":"7","key":"10.1016\/j.actbio.2026.03.031_bib0012","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/term.2698","article-title":"Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease","volume":"12","author":"Struzyna","year":"2018","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"38","key":"10.1016\/j.actbio.2026.03.031_bib0013","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1002\/adma.201602268","article-title":"Injectable and cytocompatible tough double-network hydrogels through tandem supramolecular and covalent crosslinking","volume":"28","author":"Rodell","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2026.03.031_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1346696","article-title":"Generation of contractile forces by three-dimensional bundled axonal tracts in micro-tissue engineered neural networks","volume":"17","author":"Chouhan","year":"2024","journal-title":"Front. Mol. Neurosci."},{"issue":"21\u201322","key":"10.1016\/j.actbio.2026.03.031_bib0015","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1089\/ten.tea.2014.0557","article-title":"Rebuilding brain circuitry with living micro-tissue engineered neural networks","volume":"21","author":"Struzyna","year":"2015","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.actbio.2026.03.031_bib0016","article-title":"Anatomically inspired three-dimensional micro-tissue engineered neural networks for nervous system reconstruction, modulation, and modeling","volume":"123","author":"Struzyna","year":"2017","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.actbio.2026.03.031_bib0017","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0034-5687(01)00306-1","article-title":"Tissue oxygen tension and brain sensitivity to hypoxia","volume":"128","author":"Ereci\u0144ska","year":"2001","journal-title":"Respir. Physiol."},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0018","doi-asserted-by":"crossref","first-page":"e8575","DOI":"10.1371\/journal.pone.0008575","article-title":"Mild hypoxia enhances proliferation and multipotency of human neural stem cells","volume":"5","author":"Santilli","year":"2010","journal-title":"PLoS. One"},{"issue":"12","key":"10.1016\/j.actbio.2026.03.031_bib0019","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1038\/cddis.2011.128","article-title":"Oxygen matters: tissue culture oxygen levels affect mitochondrial function and structure as well as responses to HIV viroproteins","volume":"2","author":"Tiede","year":"2011","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.actbio.2026.03.031_bib0020","article-title":"Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: an historical perspective","volume":"14","author":"Gerfen","year":"2022","journal-title":"Front. Synaptic. Neurosci."},{"issue":"520","key":"10.1016\/j.actbio.2026.03.031_bib0021","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba1659","article-title":"Promising disease-modifying therapies for Parkinson's disease","volume":"11","author":"Dawson","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.actbio.2026.03.031_bib0022","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad39a7","article-title":"3D hydrogel microfibers promote the differentiation of encapsulated neural stem cells and facilitate neuron protection and axon regrowth after complete transactional spinal cord injury","volume":"16","author":"Zhang","year":"2024","journal-title":"Biofabrication"},{"issue":"3","key":"10.1016\/j.actbio.2026.03.031_bib0023","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10571-020-00986-0","article-title":"Extracellular matrix in neural plasticity and regeneration","volume":"42","author":"Chelyshev","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"issue":"8064","key":"10.1016\/j.actbio.2026.03.031_bib0024","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"issue":"8064","key":"10.1016\/j.actbio.2026.03.031_bib0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.actbio.2026.03.031_bib0026","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.stem.2022.01.013","article-title":"A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells","volume":"29","author":"Moriarty","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.actbio.2026.03.031_bib0027","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.omtm.2019.06.008","article-title":"Partial reconstruction of the nigrostriatal circuit along a preformed molecular guidance pathway","volume":"14","author":"Ghosh","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"10","key":"10.1016\/j.actbio.2026.03.031_bib0028","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/ten.tec.2017.0244","article-title":"The effect of hypothermic and cryogenic preservation on engineered neural tissue","volume":"23","author":"Day","year":"2017","journal-title":"Tissue Eng. C. Methods"},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0029","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00006534-199807000-00012","article-title":"The survival of human skin stored by refrigeration at 4 degrees C in McCoy's 5A medium: does oxygenation of the medium improve storage time?","volume":"102","author":"DeBono","year":"1998","journal-title":"Plast. Reconstr. Surg."},{"issue":"10","key":"10.1016\/j.actbio.2026.03.031_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222597","article-title":"Strategies for the hypothermic preservation of cell sheets of human adipose stem cells","volume":"14","author":"Freitas-Ribeiro","year":"2019","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nyas.14264","article-title":"Hypothermic and cryogenic preservation of tissue-engineered human bone","volume":"1460","author":"Tam","year":"2020","journal-title":"Ann. N. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0032","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jor.23034","article-title":"Long-term storage and preservation of tissue engineered articular cartilage","volume":"34","author":"Nover","year":"2016","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.actbio.2026.03.031_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/20417314211032488","article-title":"Biopreservation of living tissue engineered nerve grafts","volume":"12","author":"Shultz","year":"2021","journal-title":"J. Tissue Eng."},{"issue":"4","key":"10.1016\/j.actbio.2026.03.031_bib0034","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00007890-198804000-00001","article-title":"Principles of solid-organ preservation by cold storage","volume":"45","author":"Belzer","year":"1988","journal-title":"Transplantation"},{"issue":"1\u20134","key":"10.1016\/j.actbio.2026.03.031_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000149797","article-title":"Hypothermic injury: the mitochondrial calcium, ATP and ROS love-hate triangle out of balance","volume":"22","author":"Brinkkoetter","year":"2008","journal-title":"Cell Physiol. Biochem."},{"issue":"3\u20134","key":"10.1016\/j.actbio.2026.03.031_bib0036","first-page":"477","article-title":"Mammalian cell injury induced by hypothermia- the emerging role for reactive oxygen species","volume":"383","author":"Rauen","year":"2002","journal-title":"Biol. Chem."},{"issue":"6","key":"10.1016\/j.actbio.2026.03.031_bib0037","first-page":"S10","article-title":"Demonstration of temperature dependence of Na(+)-K+ pump activity of human blood cells","volume":"266","author":"Honig","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.actbio.2026.03.031_bib0038","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cell.2018.01.008","article-title":"Dopamine secretion is mediated by sparse active zone-like release sites","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0039","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41536-022-00221-y","article-title":"Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson\u2019s disease","volume":"7","author":"Hiller","year":"2022","journal-title":"NPJ Regen. Med. (Baltim.)"},{"issue":"2","key":"10.1016\/j.actbio.2026.03.031_bib0040","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1172\/JCI130767","article-title":"Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models","volume":"130","author":"Song","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.actbio.2026.03.031_bib0041","article-title":"Extracellular nanomatrix-induced self-organization of neural stem cells into miniature substantia Nigra-like structures with therapeutic effects on Parkinsonian rats","volume":"6","author":"Zhang","year":"2019","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.actbio.2026.03.031_bib0042","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuroscience.2008.01.046","article-title":"Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat","volume":"152","author":"Nair-Roberts","year":"2008","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.actbio.2026.03.031_bib0043","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cne.903310302","article-title":"Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat","volume":"331","author":"German","year":"1993","journal-title":"J. Comp. Neurol."},{"issue":"13","key":"10.1016\/j.actbio.2026.03.031_bib0044","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/jnr.21748","article-title":"Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice","volume":"86","author":"Shintani","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.actbio.2026.03.031_bib0045","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1002\/ana.10482","article-title":"Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells","volume":"53","author":"Isacson","year":"2003","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.actbio.2026.03.031_bib0046","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1073\/pnas.022438099","article-title":"Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model","volume":"99","author":"Bjorklund","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0047","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stemcr.2017.04.033","article-title":"Cryopreservation maintains functionality of Human iPSC dopamine neurons and rescues parkinsonian phenotypes In vivo","volume":"9","author":"Wakeman","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0048","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/exnr.1996.0141","article-title":"The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum","volume":"141","author":"Barker","year":"1996","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.actbio.2026.03.031_bib0049","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00241123","article-title":"Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon","volume":"106","author":"Fawcett","year":"1995","journal-title":"Exp. Brain Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.03.031_bib0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14802\/jmd.22141","article-title":"Current status and future perspectives on stem cell-based therapies for Parkinson's disease","volume":"16","author":"Cha","year":"2023","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.actbio.2026.03.031_bib0051","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fnana.2014.00152","article-title":"Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update","volume":"8","author":"Brichta","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.actbio.2026.03.031_bib0052","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainresbull.2021.07.016","article-title":"Restoring lost nigrostriatal fibers in Parkinson\u2019s disease based on clinically-inspired design criteria","volume":"175","author":"Gordi\u00e1n-V\u00e9lez","year":"2021","journal-title":"Brain Res. Bull"},{"issue":"20","key":"10.1016\/j.actbio.2026.03.031_bib0053","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson\u2019s disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.actbio.2026.03.031_bib0054","doi-asserted-by":"crossref","first-page":"eaay5347","DOI":"10.1126\/sciadv.aay5347","article-title":"Development of optically controlled \u201cliving electrodes\u201d with long-projecting axon tracts for a synaptic brain-machine interface","volume":"7","author":"Adewole","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.03.031_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.isci.2019.10.004","article-title":"Bundled three-dimensional Human axon tracts derived from brain organoids","volume":"21","author":"Cullen","year":"2019","journal-title":"iScience"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126001807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126001807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:21:44Z","timestamp":1782112904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126001807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":55,"alternative-id":["S1742706126001807"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.03.031","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biopreservation of a tissue engineered nigrostriatal pathway for tract reconstruction in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}